Literature DB >> 1724784

Establishment and characterization of a human leptomeningeal cell line.

M Murphy1, J N Chen, D L George.   

Abstract

Human leptomeningeal cells grown in culture were immortalized via transfection with an SV40 large T antigen gene construct under the control of the Rous sarcoma virus promoter. This cell line, designated LTAg2B, maintained the polygonal morphology characteristic of primary cultures, and stained positively in early passage for cytokeratin, a specific marker for arachnoid cells of the leptomeninges. Additional immunofluorescent staining revealed that these cells express vimentin and desmoplakin as well; these antigens have been found together only in normal arachnoid tissue and in meningiomas, which are the neoplastic derivatives of leptomeningeal cells. Significantly, LTAg2B cells demonstrate a greatly increased life span and growth rate relative to primary cultures. The establishment of this cell line should thus facilitate studies on the cellular and molecular biology of leptomeningeal cells, as well as elucidate their roles in certain pathological situations involving the leptomeninges, such as meningitis and meningioma tumor formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724784     DOI: 10.1002/jnr.490300304

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.

Authors:  M J Pykett; J Landers; D L George
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Arachnoid cell involvement in the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage.

Authors:  Zhao-liang Xin; Xiao-kang Wu; Jian-rong Xu; Xi Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

3.  Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space. Immunhistochemical study.

Authors:  O Motohashi; M Suzuki; N Shida; K Umezawa; T Ohtoh; Y Sakurai; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier.

Authors:  Kazuto Yasuda; Cynthia Cline; Peter Vogel; Mihaela Onciu; Soghra Fatima; Brian P Sorrentino; Ranjit K Thirumaran; Sean Ekins; Yoshihiro Urade; Ko Fujimori; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2013-01-08       Impact factor: 3.922

Review 5.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

6.  Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.

Authors:  M Simon; T W Park; G Köster; R Mahlberg; M Hackenbroch; J Boström; T Löning; J Schramm
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

7.  In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM).

Authors:  Isamu Ishiwata; Chieko Ishiwata; Emiko Ishiwata; Yoshiro Sato; Kazushige Kiguchi; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2004-12       Impact factor: 4.174

8.  Reduced expression of neurofibromin in human meningiomas.

Authors:  V Sundaram; J H Lee; J A Harwalkar; D J Stein; M Roudebush; D W Stacey; M Golubic
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Characterization of cytoskeletal and junctional proteins expressed by cells cultured from human arachnoid granulation tissue.

Authors:  David W Holman; Deborah M Grzybowski; Bhavya C Mehta; Steven E Katz; Martin Lubow
Journal:  Cerebrospinal Fluid Res       Date:  2005-10-13

Review 10.  Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers.

Authors:  Mariana Castro Dias; Josephine A Mapunda; Mykhailo Vladymyrov; Britta Engelhardt
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.